Uppername	compound_id	compound_name	equivalent_structures	primary_moa	moas	primary_target_gene_symbol	phase	rdkit_smiles	CAS	cas	nsc	name	testing_status	mechanism	synonyms	cas.y	found	duplicated
4SC-202	c1622ee6d20477f6df842ea8aa9f85a9	4SC-202	[NCGC00384199]	"Histone Deacetylase 2, Class I Inhibitor"	"[Histone Deacetylase 2, Class I Inhibitor, Hdac Inhibitor, Histone Deacetylase 3, Class I Inhibitor, Histone Deacetylase 1, Class I Inhibitor]"	HDAC1	[Phase I/II]	[Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1]	910462-43-0	910462430	759905	4SC-202	Clinical trial	HDAC	4sc-202|;4sc-202;(e)-2-(3-(1-((4-(1-methyl-1h-pyrazol-4-yl)pheny...|(e)-2-(3-(1-((4-(1-methyl-1h-pyrazol-4-yl)phenyl)sulfony...		name	FALSE
A-1210477	e07db19790690ef9552225d52e4db01f	A-1210477	[NCGC00387725]	Mcl-1 Inhibitor	"[Mcl-1 Inhibitor, Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Inhibitor]"	MCL1	"[Preclinical, Unknown]"	[Cc1nn(C)c(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)n(CCN3CCOCC3)c12]	1668553-26-1	1668553261	784817	A-1210477	Clinical trial	MCL1	a1210477 hcl|a 1210477 hcl|a-1210477 hcl|a-9036|A-1210477		name	FALSE
ACTB-1003	68615f8aafc20fbaa7cd67e8b136e5b8	Actb-1003	[NCGC00481611]	Ribosomal Protein S6 Kinase Alpha-1 Inhibitor	"[Ribosomal Protein S6 Kinase Alpha-1 Inhibitor, Fgfr Inhibitor, Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Ribosomal Protein S6 Kinase Beta-1 Inhibitor, Angiopoietin-1 Receptor Inhibitor, Fibroblast Growth Factor Receptor Inhibitor]"	RPS6KA1	"[Unknown, Phase I]"	[COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1]	939805-30-8	939805308	799324	ACTB-1003	NA	NA	NA		name	FALSE
ALOIN	8b260edb5ba2af7bd658cab06dcbcc25	Aloin	"[NCGC00389192, NCGC00178216, NCGC00183867, NCGC00386161, NCGC00095271, NCGC00389730]"	Stimulant Laxative	[Stimulant Laxative]		"[Preclinical, Unknown]"	"[O=C1c2c(O)cccc2C(O[C@@H]2OC(CO)C(O)C(O)C2O)c2cc(CO)cc(O)c21, O=C1c2c(O)cccc2C(C2OC(CO)C(O)C(O)C2O)c2cc(CO)cc(O)c21, O=C1c2c(O)cccc2C(OC2OC(CO)C(O)C(O)C2O)c2cc(CO)cc(O)c21, O=C1c2c(O)cccc2C([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21, O=C1c2c(O)cccc2[C@H]([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21, O=C1c2c(O)cccc2C(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21, O=C1c2c(O)cccc2[C@@H]([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21]"	8024-48-4	8024484	4722	ALOIN			aloin|aloins		name	FALSE
AMG-900	e352abd55182307c2db898663bf2b75b	AMG-900	[NCGC00263094]	Aurora-a/b/c Kinase Inhibitor	"[Aurora-a/b/c Kinase Inhibitor, Aurora Kinase A Inhibitor, Aurora Kinase B Inhibitor, Aurora Kinase C Inhibitor]"	AURKA	[Phase I]	[Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1]	945595-80-2	945595802	761069	AMG-900	Clinical trial	"PK:STK,AURK"	amg900|n-[4-[[3-(2-amino-4-pyrimidinyl)-2-pyridinyl]oxy]phenyl]...|AMG-900		name	FALSE
ANCITABINE HYDROCHLORIDE	4cab5a0efc708d673a02fcef8e65beb1	ANCITABINE HYDROCHLORIDE	"[MLS001032024, NCGC00178156, NCGC00346726, NCGC00260827, NCGC00142470, NCGC00017239, NCGC00161845, MLS001173324, NCGC00093632, NCGC00015098, NCGC00263968, NCGC00255140, NCGC00159322, MLS000766237, NCGC00095104]"	Antiviral	"[Antiviral, Dna-directed Dna Polymerase Inhibitor]"	POLB	"[Unknown, Approved]"	"[Cl.N=c1ccn2c(n1)O[C@H]1C(O)[C@@H](CO)O[C@H]12, Cl.N=c1ccn2c(n1)OC1C(O)C(CO)OC12, N=c1ccn2c(n1)O[C@@H]1[C@@H](O)[C@H](CO)O[C@@H]12, Cl.N=c1ccn2c(n1)O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]12, N=c1ccn2c(n1)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]12, N=c1ccn2c(n1)O[C@@H]1C2O[C@H](CO)[C@H]1O, N=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)C[C@H]12, Cl.N=c1ccn2c(n1)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]12, N=c1ccn2c(n1)O[C@H]1C(O)[C@@H](CO)O[C@H]12, N=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12, CC(=O)O.N=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12, Cl.N=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12, N=c1ccn2c(n1)OC1C(O)C(CO)OC12, CC(=O)O.N=c1ccn2c(n1)OC1C(O)C(CO)OC12, N=c1ccn2c(n1)O[C@H]1[C@@H](O)[C@@H](CO)O[C@H]12, N=c1ccn2c(n1)O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]12, N=c1ccn2c(n1)O[C@H]1[C@@H]2O[C@@H](CO)[C@H]1O]"	31698-14-3	31698143	"758671, 145668"	"ANCITABINE HYDROCHLORIDE, ANCITABINE HYDROCHLORIDE"	", "	"Ds, Ds"	"ancitabine hydrochloride|cyclocytidine|cyclocytidine hydrochloride, cyclocytidine hydrochloride|cytosine, 1.beta.-d-arabinofuranosyl-2,2'-anhydro-, hydr...|2,2'-anhydroarabinosylcytosine hydrochloride|cyclocmp hydrochloride|2,2'-o-cyclocytidine hydrochloride|2,2'-o-cyclocytidine|2,2'-anhydrocytarabine hcl|1.beta.-d-arabinofuranosylcytosine, 2,2'-anhydro-, hydro...|6h-furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2...|2,2'-anhydrocytidine hydrochloride|2,2'-anhydrocytarabine hydrochloride|octd hydrochloride|2,2'-anhydro-1.beta.-d-arabinofuranosylcytosine hydrochl...|ancitabine hydrochloride|2,2'-anhydroaracytidine hydrochloride|nsc-145668|o2,2'-cyclocytidine, monohydrochloride|cyclocytidine|2,2'-cyclocytidine hydrochloride"	"10212256, 10212256"	"name, name"	"TRUE, TRUE"
ARQ-087(DERAZANTINIB)	8d036155d25a4158500cd006d87dd47a	Arq-087(derazantinib)	[NCGC00509932]	Fibroblast Growth Factor Receptor Inhibitor	"[Fibroblast Growth Factor Receptor Inhibitor, Fgfr Inhibitor]"	FGFR1	[Phase III]	[COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1]	1234356-69-4	1234356694	792996	ARQ-087	Clinical trial	PK:FGFR	ARQ-087_Peak 1|ARQ-087	1234356694	cas	FALSE
ARQ-621	317bff68cbc5936fd2e567bb1fda2030	ARQ-621	[NCGC00386362]	Kinesin-like Protein Kif11 Inhibitor	"[Kinesin-like Protein Kif11 Inhibitor, Kinesin-like Spindle Protein Inhibitor]"	KIF11	[Phase I]	[C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F]	1095253-39-6	1095253396	771644	ARQ-621	Clinical trial	CDH16|KIF11	arq-621|n-(3-amino-propyl)-3-chloro-2-fluoro-n-[(r)-1-(7-chloro-...		name	FALSE
ARTEMETHER	b2b77cf45b400725ff2a3a4c938c5a91	Artemether	"[NCGC00390188, NCGC00507748, NCGC00485106, NCGC00260984, NCGC00389516, NCGC00164591, NCGC00386152]"	Antimalarial Agents	"[Antimalarial Agents, Ferriprotoporphyrin Ix Interacts, Anti-malarial]"	PfATP6	"[Unknown, Approved]"	"[CO[C@@H]1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3, CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3, CO[C@H]1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)C42OO3, CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@@H]4[C@@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3, CO[C@H]1O[C@@H]2O[C@@]3(C)CCC4[C@H](C)CCC([C@H]1C)[C@]42OO3, COC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3, COC1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3, COC1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3, CO[C@H]1O[C@@H]2O[C@]3(C)CC[C@@H]4[C@@H](C)CC[C@H]([C@H]1C)[C@]24OO3, CO[C@H]1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3, COC1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H](C1C)[C@]42OO3, CO[C@H]1O[C@@H]2OC[C@@]3(C)C[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3, COC1O[C@@H]2O[C@]3(C)CCC4[C@H](C)CCC([C@H]1C)[C@]42OO3, CO[C@H]1O[C@@H]2OC3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3]"	71963-77-4	71963774	665970	ARTEMETHER		NonCan:Mal	artemether		name	FALSE
ASP-3026	3dbb7ad07b9da849487c40a37111a26c	Asp-3026	[NCGC00345791]	Alk Inhibitor	"[Alk Inhibitor, Alk Tyrosine Kinase Receptor Inhibitor, Echinoderm Microtubule-associated Protein-like 4-alk Tyrosine Kinase Receptor (eml4- Alk) Inhibitor, Anaplastic Lymphoma Kinase (alk) Inhibitor]"	ALK	"[Discontinued, Phase I]"	[COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1]	1097917-15-1	1097917151	765865	ASP-3026	Clinical trial	PK:ALK	asp-3026 trihydrochloride|n-[2-methoxy-4-(4-methylpiperazin-1-yl)piperidin-1-yl]ph...|;asp-3026 trihydrochloride;n-[2-methoxy-4-(4-methylpiper...|ASP-3026		name	FALSE
AT-13148	5153fd283cbfe53edfc008786eee777b	AT-13148	"[NCGC00538425, NCGC00589154, NCGC00386423]"	Akt Serine/threonine Kinase Inhibitor	"[Akt Serine/threonine Kinase Inhibitor, Akt Inhibitor, Rho-associated Protein Kinase 1 Inhibitor, Camp-dependent Protein Kinase Alpha Inhibitor, Protein Kinase C (pkc) Inhibitor, Cgmp-dependent Protein Kinase Inhibitor, Rho-associated Protein Kinase 2 Inhibitor, Ribosomal Protein S6 Kinase Beta Inhibitor, Camp-dependent Protein Kinase (pka) Inhibitor]"	AKT1	"[Unknown, Phase I]"	"[NC[C@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1, NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1, NCC(O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1]"	1056901-62-2	1056901622	"799337, 771650"	"AT-13148, AT-13148"	"NA, Clinical trial"	"NA, PK:AKT"	"NA, at-13148|(s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-ph...|tcrs-191"	", "	"name, name"	"TRUE, TRUE"
AZD-5438	354b6344690e5d19f8b7559f28e16fdc	Azd-5438	[NCGC00346617]	Cyclin-dependent Kinase 1/cyclin B Inhibitor	"[Cyclin-dependent Kinase 1/cyclin B Inhibitor, Cdk1/2 Inhibitor, Cdk1/cyclin B Inhibitor, Cdk2/cyclin A Inhibitor, Cdk2/cyclin E Inhibitor, Cdk1/cyclin B1 Inhibitors;cdk2/cyclin A Inhibitors;cdk2/cyclin E Inhibitors]"	CDK1	"[Discontinued, Unknown, Phase I]"	"[CS(=O)(=O)O.Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C, Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C]"	602306-29-6	602306296	799348	AZD-5438	NA	NA	NA		name	FALSE
AZD-6482	7e66ea85598351e398789b86267dfb6b	Azd-6482	"[NCGC00389715, NCGC00263154]"	Pi3kbeta Inhibitor	"[Pi3kbeta Inhibitor, Pi3kb/d Inhibitor, Phosphatidylinositol 3-kinase Beta Isoform Inhibitor, Phosphatidylinositol 3-kinase Delta Isoform Inhibitor]"	PIK3CB	"[Discontinued, Unknown, Phase I]"	"[Cc1cc(C(C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1, Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1, Cc1cc([C@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1]"	1173900-33-8	1173900338	799349	AZD-6482	NA	NA	NA		name	FALSE
AZD4547	ed95d641577b53da181ff0d8f2558a4a	Azd4547	"[NCGC00378876, NCGC00485936, NCGC00389612, NCGC00346713]"	Fgfr 3 Inhibitor	"[Fgfr 3 Inhibitor, Fgfr 1/2/3 Inhibitor, Fibroblast Growth Factor Receptor Inhibitor]"	FGFR1	"[Phase II/III, Phase II, Unknown]"	"[COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1, COc1cc(CCC2=NN=C(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)C2)cc(OC)c1, COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)[nH]n2)cc(OC)c1, COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1]"	1035270-39-3	1035270393	764239	AZD-4547	Clinical trial	"PK:YK,FGFR,FGFR1,FGFR2,FGFR3"	azd-4547|inb0001243|;azd-4547;inb0001243	1035270393	cas	FALSE
BAY-1895344	3e4e0113e0193e434e38b0d2d8e6105d	BAY-1895344	[NCGC00510268]	Atr Kinase Inhibitor	"[Atr Kinase Inhibitor, Serine-protein Kinase Atr Inhibitor]"	ATR	[Phase I]	[C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1]	1876467-74-1	1876467741	817275	BAY1895344	NA	NA	bay1895344|ct-bay189|bay-1895344	1876467741	cas	FALSE
BETA-LAPACHONE	2c8f3c83de3acb6a9c7a1581c2a894cb	beta-Lapachone	"[NCGC00094066, NCGC00261402, NCGC00015598]"	Dna Topoisomerase I/ii Inhibitors	"[Dna Topoisomerase I/ii Inhibitors, Tryptophan 2,3-dioxygenase Inhibitor, Tryptophan 2,3-dioxygenase (tdo) Inhibitor, Indoleamine 2,3-dioxygenase 1 Inhibitor, Transcription Factor E2f Modulators, Dna Topoisomerase I Inhibitor, Dna Topoisomerase Ii Inhibitor]"	TDO2	"[Phase II, Unknown, Phase I]"	[CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O]	4707-32-8	4707328	813862	Lapachone	Clinical trial		cs-3680|arq501|.beta.-lapachone|arq-501|CO-501|MB-660|lapachone|beta-Lapachone	4707328	cas	FALSE
BI-847325	d6cc0b0917ca0f2438070a9970637db7	BI-847325	[NCGC00481575]	Aurora Kinase B Inhibitor	"[Aurora Kinase B Inhibitor, Aurora Kinase Inhibitor, Dual Specificity Mitogen-activated Protein Kinase Kinase 2 Inhibitor, Aurora Kinase A Inhibitor, Aurora Kinase C Inhibitor, Dual Specificity Mitogen-activated Protein Kinase Kinase 1 Inhibitor]"	AURKB	"[Unknown, Phase I]"	[CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1]		NA	799360	BI-847325	NA	NA	NA		name	FALSE
BI-D1870	0349a36d2ced17ec3e4edc6415097cb6	Bi-d1870	"[NCGC00651728, NCGC00386218, NCGC00263086]"	Mapkap-k1 (rsk; P90rsk) Inhibitor	"[Mapkap-k1 (rsk; P90rsk) Inhibitor, Rsk Inhibitor, Ribosomal Protein S6 Kinase Alpha-1 Inhibitor, Ribosomal Protein S6 Kinase Alpha-2 Inhibitor, Ribosomal Protein S6 Kinase Alpha-3 Inhibitor]"	RPS6KA1	"[Preclinical, Unknown]"	"[CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C, CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)[C@H]1C, CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=N)C1C]"	501437-28-1	501437281	747342	BI-D1870			;bi-d1870|bi-d1870		name	FALSE
BMS-599626	6e8d10357827c30f0336d84b635d6d00	BMS-599626	"[NCGC00346483, NCGC00389718]"	Egfr (her1; Erbb1) Inhibitor	"[Egfr (her1; Erbb1) Inhibitor, Her2, Her3, Her4 Inhibitor, Epidermal Growth Factor Receptor Inhibitor, Egfr Inhibitor, Receptor Tyrosine-protein Kinase Erbb-4 Inhibitor, Receptor Tyrosine-protein Kinase Erbb-3 Inhibitor, Receptor Tyrosine-protein Kinase Erbb-2 Inhibitor]"	EGFR	"[Phase 1, Phase I]"	"[Cc1c(NC(=O)OCC2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12, Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12]"	8173837-23-1	8173837231	764135	BMS-599626	Clinical trial	"PK:YK,EGFR,ERBB2"	bms-599626|ct-bms59|AC-480 (free base)|ac 480|N-[4-[1-(3-Fluorobenzyl)-1H-indazol-5-ylamino]-5-methylp...|AC-480	714971092	name	FALSE
BMS-777607	3a77eafc5a79aedcddf33b66a70e064c	BMS-777607	[NCGC00263157]	Hgfr (met; C-met) Inhibitor	"[Hgfr (met; C-met) Inhibitor, Tyrosine-protein Kinase Mer Inhibitor, Hgfr Inhibitor, Macrophage Stimulating Protein Receptor, Tyrosine-protein Kinase Receptor Tyro3 Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inbitor, Hepatocyte Growth Factor Receptor Inhibitor, Tyrosine-protein Kinase Receptor Ufo Inhibitor]"	MET	"[Phase II, Phase I]"	[CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1]	1025720-94-8	1025720948	764090	BMS-777607	Clinical trial	"PK:MET,RON"	bms 777607|;bms 777607;s1561|s1561|BMS-777607|ASLAN-002	1196681443	name	FALSE
BMS-863233	1afe0364ffa3bfda364d3e2169522327	BMS-863233	"[NCGC00390286, NCGC00389230, NCGC00378617]"	Cdk 7 Inhibitor	"[Cdk 7 Inhibitor, Cell Division Cycle 7-related Protein Kinase Inhibitor, Serine/threonine-protein Kinase Pim1 Inhibitor]"	CDK7	"[Phase II, Phase I/II, Unknown]"	"[O=c1nc(C2CCCN2)[nH]c2c1oc1ccc(Cl)cc12, Cl.O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12, O=c1[nH]c([C@@H]2CCCN2)nc2c1oc1ccc(Cl)cc12, O=c1nc([C@@H]2CCCN2)[nH]c2c1oc1ccc(Cl)cc12, O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12]"	1169562-71-3	1169562713	775771	BMS-863233	Clinical trial	"PK:CDC7,CDK9"	"xl-413|bms-863233|(r)-8-chloro-2-(pyrrolidin-2-yl)benzofuro[3,2-d]pyrimidi..."	1169558386	name	FALSE
BP-1-102	14e9a40b7f25978e4cb3d6c11dd7a2cf	BP-1-102	[NCGC00345808]	Signal Transducer And Activator Of Transcription 3 Inhibitor	"[Signal Transducer And Activator Of Transcription 3 Inhibitor, Stat-3 Inhibitor]"	STAT3	"[Preclinical, Unknown]"	[CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F]		NA	764037	BP-1-102	Clinical trial	STAT|IL6|STAT3	"bp-1-102|4-[n-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-n-met..."		name	FALSE
CANERTINIB	3cc40ca1f22aec001487fbab25bc8905	Canertinib	"[NCGC00182713, MLS004774146]"	Egfr (her1; Erbb1) Inhibitor	"[Egfr (her1; Erbb1) Inhibitor, Epidermal Growth Factor Receptor Inhibitor, Egfr Inhibitor, Receptor Tyrosine-protein Kinase Erbb-4 Inhibitor, Receptor Tyrosine-protein Kinase Erbb-2 Inhibitor]"	EGFR	"[Phase III, Phase II]"	"[C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl, C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1]"	267243-28-7	267243287	801011	CANERTINIB	NA	NA	NA		name	FALSE
CC-115	107bedab0121360dda9d295123131a6d	CC-115	"[NCGC00507843, NCGC00522580]"	Dna-pk Inhibitor	"[Dna-pk Inhibitor, Dna-dependent Protein Kinase Inhibitor, Serine/threonine-protein Kinase Mtor Inhibitor]"	PRKDC	"[Phase II, Unknown]"	"[CCN1C(=O)CN=C2NC=C(c3ccc(-c4nnc[nH]4)nc3C)N=C21, CCN1C(=O)CNc2ncc(-c3ccc(-c4nc[nH]n4)nc3C)nc21]"	1300118-55-1	1300118551	793151	CC-115	Clinical trial	PK:MTOR	cc-115|cc115|a-9068	1228013157	name	FALSE
CCT-251545	8ace74a9b955efbb2c8c53218e479492	Cct-251545	[NCGC00509936]	Cyclin-dependent Kinase 19 Inhibitor	"[Cyclin-dependent Kinase 19 Inhibitor, Cdk 8/19 Inhibitor, Cyclin-dependent Kinase 8 Inhibitor]"	CDK8	"[Preclinical, Unknown]"	[Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1]	1661839-45-7	1661839457	784591	CCT-251545	Clinical trial	Wnt	cct-251545|cct 251545|a-1387|cct251545		name	FALSE
CEP-32496	70fd9626f86e04168d8809825d3cc6d7	Cep-32496	[NCGC00386234]	Proto-oncogene Tyrosine-protein Kinase Receptor Ret Inhibitor	"[Proto-oncogene Tyrosine-protein Kinase Receptor Ret Inhibitor, Egfr Inhibitor, Serine/threonine-protein Kinase B-raf Inhibitor, Epidermal Growth Factor Receptor Inhibitor]"	RET	"[Phase I/II, Unknown, Phase I]"	"[COc1cc2ncnc(Oc3cccc(N[11C](=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC.Cl, COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC]"	1227678-26-3	1227678263	"800070, 776043"	"CEP-32496, CEP-32496"	"NA, Clinical trial"	"NA, PK:BRAF"	"NA, cep-32496|cs-1115"	", 1188910760"	"name, name"	"TRUE, TRUE"
CERDULATINIB	8e0c616141d06fdf3aaaa639729c2872	Cerdulatinib	[NCGC00386415]	Tyk2 Inhibitor	"[Tyk2 Inhibitor, Tyrosine-protein Kinase Syk Inhibitor, Jak Inhibitor]"	SYK	"[Phase I/II, Unknown]"	[CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1]	1198300-79-6	1198300796	825827	Cerdulatinib	NA	NA	ct-cerd|prt2070|cerdulatinib|prt062070	1198300796	cas	FALSE
CH-5132799	b77f5e8268629bf78dc6dbc42873137b	Ch-5132799	[NCGC00346650]	Phosphatidylinositol 3-kinase Beta Isoform Inhibitor	"[Phosphatidylinositol 3-kinase Beta Isoform Inhibitor, Pi3kalpha, Beta, Gamma Inhibitor, Phosphatidylinositol 3-kinase Alpha Isoform Inhibitor, Phosphatidylinositol 3-kinase Catalytic Subunit Gamma Inhibitor]"	PIK3CA	"[Preclinical, Phase I]"	[CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21]	1007207-67-1	1007207671	"762382, 800984"	"CH-5132799, CH-5132799"	"Clinical trial, NA"	"PK:PIK3, NA"	"ch-5132799|;ch-5132799|PA-799, NA"	", "	"name, name"	"TRUE, TRUE"
COPANLISIB	9dbf8d63143cbc8bdb77733bd0e2b90e	Copanlisib	[NCGC00346457]	Phosphatidylinositol 3-kinase Alpha Isoform Inhibitor	"[Phosphatidylinositol 3-kinase Alpha Isoform Inhibitor, Pi3k Alpha/delta Inhibitor, Phosphatidylinositol 3-kinase Delta Isoform Inhibitor]"	PIK3CA	"[Phase II, Approved]"	"[COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21, COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21.Cl.Cl]"	1032568-63-0	1032568630	809693	Copanlisib	FDA approved	PK:PIK3	bay-80-6946|copanlisib|aliqopa|SRS18	1032568630	cas	FALSE
CUDC-101	a392de6efa5ae267d661a58f1bd7016c	CUDC-101	[NCGC00263177]	Egfr (her1; Erbb1) Inhibitor	"[Egfr (her1; Erbb1) Inhibitor, Egfr Inhibitor, Epidermal Growth Factor Receptor Inhibitor, Histone Deacetylase (hdac) Inhibitor, Receptor Tyrosine-protein Kinase Erbb-2 Inhibitor]"	EGFR	"[Discontinued, Unknown, Phase I]"	"[C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)N[O-])cc23)c1.[Na+], C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1.O=C(O)CC(O)(CC(=O)O)C(=O)O, C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1, C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1.Cl, C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1.O=C(O)C(O)C(O)C(=O)O]"	1012054-59-9	1012054599	800081	CUDC-101	NA	NA	NA		name	FALSE
DACTOLISIB	c345f6a0937a7854058e30e159cc118c	DACTOLISIB	[NCGC00187481]	Mtor Inhibitor	"[Mtor Inhibitor, Serine/threonine-protein Kinase Mtor Inhibitor, Phosphatidylinositol 3-kinase Catalytic Subunit Beta Inhibitor, Phosphatidylinositol 3-kinase Alpha Isoform Inhibitor, Phosphatidylinositol 3-kinase Catalytic Subunit Gamma Inhibitor, Phosphatidylinositol 3-kinase Catalytic Subunit Delta Inhibitor, Frap1, Pi3k Alpha, Beta, Gamma, Delta Inhibitor]"	MTOR	"[Phase II, Unknown]"	"[CS(=O)(=O)O.Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21, Cc1ccc(S(=O)(=O)O)cc1.Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21, Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21]"	915019-65-7	915019657	800085	DACTOLISIB	NA	NA	NA		name	FALSE
DAROLUTAMIDE (ODM-201)	3b42d4b85766a8b59d4d7dfda6ecff04	Darolutamide (odm-201)	"[NCGC00484078, NCGC00482785]"	Androgen Receptor Antagonist	[Androgen Receptor Antagonist]	AR	[Phase III]	"[CC(O)c1cc(C(=O)N[C@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1, CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1]"	1297538-32-9	1297538329	825331	Darolutamide	NA	NA	bay-1841788|bay1841788|darolutamide|cs-5174	1297538329	cas	FALSE
EMD-534085	53c72e55f5e3e7532de7224628f0a1a6	emd-534085	[NCGC00522550]	Kinesin-like Spindle Protein Kif11 (ksp; Eg5) Inhibitor	"[Kinesin-like Spindle Protein Kif11 (ksp; Eg5) Inhibitor, Kinesin-like Protein Kif11 Inhibitor]"	KIF11	"[Unknown, Phase I]"	[CN(C)CCNC(=O)NC[C@H]1CC[C@@H]2[C@H](O1)c1cc(C(F)(F)F)ccc1N[C@H]2c1ccccc1]	858668-07-2	858668072	763564	EMD-534085	Clinical trial	CDH16|Kinesin|PK:YK	"emd-534085|1-[[(2r,4as,5r,10bs)-5-phenyl-9-(trifluoromethyl)-3,4,4a..."		name	FALSE
ENCORAFENIB	37eeb556432f2c2a9059ccf00376c95f	ENCORAFENIB	[NCGC00378599]	Serine/threonine-protein Kinase B-raf (val600glu Mutant) Inhibitor	"[Serine/threonine-protein Kinase B-raf (val600glu Mutant) Inhibitor, Raf Kinase Inhibitor B (v600e Mutant)]"	BRAF	"[Phase III, Unknown, Approved]"	"[COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1, COC(=O)N[C@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1]"	1269440-17-6	1269440176	778304	ENCORAFENIB	FDA approved	PK:BRAF	lgx-818|encorafenib		name	FALSE
ENMD-981693	b6e953c5473c215c61a1a320d78fd936	ENMD-981693	[NCGC00263178]	Vascular Endothelial Growth Factor Receptor 2 Inhibitor	"[Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Aurora-a Inhibitor, Aurora Kinase A Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inbitor]"	KDR	"[Phase II, Unknown]"	"[Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1, Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1, Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1.O=C(O)C(O)C(O)C(=O)O]"	1291074-87-7	1291074877	758245	ENMD-2076	Clinical trial	"PK:STK,AURK"	enmd-2076|s1181|ENMD-98169|ENMD-981693	934353761	synonym	FALSE
ENSARTINIB	9e119d8549fdf9fd94ee3ee61e14aecc	Ensartinib	[NCGC00510479]	Alk Tyrosine Kinase Receptor Inhibitor	"[Alk Tyrosine Kinase Receptor Inhibitor, Alk Inhibitor, Alk Tyrosine Kinase Receptor (leu1196met Mutant) Inhibitor]"	ALK	"[Phase III, Unknown]"	[C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl]	1365267-27-1	1365267271	793150	ENSARTINIB	Clinical trial	PK:ALK	x-396|a-6020|x396|ensartinib	1370651209	name	FALSE
ERGOSTEROL	3cdb4cbcc8a2c339b9a667999d1ad554	Ergosterol	"[NCGC00013734, NCGC00095486, NCGC00096845, NCGC00168889]"	"Nitric Oxide Synthase, Inducible Inhibitor"	"[Nitric Oxide Synthase, Inducible Inhibitor, Sterol (fungal Cell Wall), Nf-kappab (nfkb) Activation Inhibitor, Platelet-activating Factor Acetylhydrolase Inhibitor, Sterol O-acyltransferase 1 Inhibitor, Oxysterols Receptor Lxr-alpha Agonist, Aldose Reductase Inhibitor, Prostaglandin G/h Synthase 2 Expression Inhibitor]"	NOS2	"[Not determined, Preclinical, Unknown]"	"[CC(C)[C@@H](C)/C=C\[C@@H](C)[C@@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C, CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C, CC(C)C(C)/C=C/C(C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC21C, CC(C)C(C)/C=C\C(C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC21C, CC(C)C(C)C=CC(C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC21C, CC(C)[C@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C, CC(/C=C\[C@H](C)C(C)C)[C@@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C]"	57-87-4	57874	62791	ERGOSTEROL	NA	NA	ergosterol		name	FALSE
EZATIOSTAT	fa8beb966d261edfbc7f85d04d279d62	EZATIOSTAT	"[NCGC00263221, NCGC00389375]"	Glutathione-s-transferase P Inhibitor	"[Glutathione-s-transferase P Inhibitor, Glutathione-s-transferase P1 (gstp1) Inhibitor, Glutathione-s-transferase Pi 1 Inhibitor]"	GSTP1	"[Phase II, Unknown]"	"[CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1, CCOC(=O)C(N)CCC(=O)NC(CSCc1ccccc1)C(=O)NC(C(=O)OCC)c1ccccc1, CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1.Cl]"	168682-53-9	168682539	758484	EZATIOSTAT	Clinical trial	"GSTP1|PK:STK,ROS1"	ezatiostat hydrochloride|api0005209|TLK-199|ezatiostat|Telintra	286942970	name	FALSE
GANDOTINIB	23d41b31a6fb151abbb729bd0481a4a5	Gandotinib	[NCGC00345461]	Tyrosine-protein Kinase Jak2 Inhibitor	"[Tyrosine-protein Kinase Jak2 Inhibitor, Jak2 Inhibitor]"	JAK2	[Phase II]	"[Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)[nH]n1, Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1]"	1229236-86-5	1229236865	764820	GANDOTINIB	Clinical trial	"PK:JAK,JAK2,JAK3"	s2179|ly2784544|ly-2784544|gandotinib		name	FALSE
GDC-0152	4ca0f1d944573253eaf6a67dbe659bdc	Gdc-0152	"[NCGC00389226, NCGC00386277]"	Iap Inhibitor	"[Iap Inhibitor, Inhibitor Of Apoptosis Protein 3 Antagonist, Inhibitor Of Apoptosis Proteins (iap) Inhibitor]"	XIAP	"[Unknown, Phase I]"	"[CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1, CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1.O=C(O)C(F)(F)F, CN[C@H](C)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1, CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1, CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1.Cl]"	873652-48-3	873652483	765898	GDC-0152	Clinical trial	IAP	GDC-0152		name	FALSE
GNE-140	a4d28c0f29b23c2cb6851ccd5402afa1	Gne-140	[NCGC00388532]		[]		[]	[O=C1NC(c2ccc(N3CCOCC3)cc2)(c2ccsc2)CC(O)=C1Sc1ccccc1Cl]		NA	799908	GNE-140	Clinical trial	LDHA	gne140|gne-140|cs-5958	1802977612	name	FALSE
GSK-1059615	b06cd05b0f003423e20ad220faa690f8	Gsk-1059615	"[NCGC00346509, NCGC00389323]"	Pi3kalpha Inhibitor	"[Pi3kalpha Inhibitor, Phosphatidylinositol 3-kinase Alpha Isoform Inhibitor]"	PIK3CA	"[Discontinued, Phase I]"	"[O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1, O=C1NC(=O)/C(=C\c2ccc3nccc(-c4ccncc4)c3c2)S1]"	958852-01-2	958852012	801012	GSK-1059615	NA	NA	NA		name	FALSE
GSK-2194069	4940e63f078b5a6c1a9f75c1f76056a3	Gsk-2194069	[NCGC00387475]	Fatty Acid Synthase (fas) Inhibitor	"[Fatty Acid Synthase (fas) Inhibitor, Fatty Acid Synthase Inhibitor]"	FASN	"[Preclinical, Unknown]"	[O=C(C1CC1)N1CC[C@@H](Cc2n[nH]c(=O)n2-c2ccc(-c3ccc4occc4c3)cc2)C1]	1332331-08-4	1332331084	792955	GSK-2194069	Clinical trial	FAS|FASN	gsk2194069|gsk-2194069|a-6000	1332331211	name	FALSE
GW441756X	89aa5595892380b79e7a12cac9b144c7	GW441756X	"[NCGC00161398, NCGC00242139, NCGC00165797]"	Tropomyosin Related Kinase A (trka) Inhibitor	"[Tropomyosin Related Kinase A (trka) Inhibitor, Leucine-rich Repeat Kinase 2 Inhibitor, Trk A Inhibitor, High Affinity Nerve Growth Factor Receptor Inhibitor]"	NTRK1	"[Preclinical, Unknown]"	"[Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21, Cn1cc(/C=C2/C(=O)Nc3cccnc32)c2ccccc21, Cn1cc(/C=C2\C(=O)Nc3cccnc32)c2ccccc21]"	504433-23-2	504433232	756236	GW441756X	NA	NA	gw441756x|;gw441756x		name	FALSE
GW768505A	9d6268ccbc4cf93bd915125ff9131932	GW768505A	[NCGC00242057]	Tie-2 Kinase Inhibitor	"[Tie-2 Kinase Inhibitor, Angiopoietin-1 Receptor Inhibitor]"	TEK	"[Preclinical, Unknown]"	"[COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1, COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl]"	501693-25-0	501693250	756332	GW768505A	NA	NA	;gw768505a|gw768505a		name	FALSE
IMD-0354	9ce1313d11629f72206c606a70a51b45	IMD-0354	[NCGC00165811]	Ikk-2 Inhibitor	"[Ikk-2 Inhibitor, Ikk Beta Inhibitor, Nf-kappab (nfkb) Activation Inhibitor, Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta Inhibitor, Nf-kappab Activation Inhibitor]"	IKBKB	"[Unknown, Phase I]"	[O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O]	978-62-1	978621	800773	IMD-0354	NA	NA	NA		name	FALSE
INK-128	55ab1a13e591df82157c8aaeeeb95cb0	INK-128	[NCGC00346654]	Mtorc1/2 Inhibitor	"[Mtorc1/2 Inhibitor, Mtor Complex 1 (mtorc1) Inhibitor, Mtor Complex 2 (mtorc2) Inhibitor, Serine/threonine-protein Kinase Mtor Inhibitor]"	MTOR	"[Phase II, Unknown, Phase I]"	"[CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21, [2H]C([2H])([2H])C([2H])(n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)C([2H])([2H])[2H]]"	1224844-38-5	1224844385	780880	3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1H-pyrazolo[3...	NA	NA	3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1h-pyrazolo[3...|ink-128	1224844385	cas	FALSE
JNJ-28312141	a8cd6dbc6807edec6a56bd1448e972dc	Jnj-28312141	[NCGC00345853]	Colony Stimulating Factor 1 Receptor Inhibitor	"[Colony Stimulating Factor 1 Receptor Inhibitor, Csf1r (c-fms) Inhibitor]"	CSF1R	"[Unknown, Phase I]"	"[CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl, CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1]"	885692-52-4	885692524	754345	JNJ-28312141	Clinical trial	"PK:YK,CSF1R"	"hcl salt of free base-jnj-28312141 (csfr-1)|jnj-28312141, hcl salt|1h-imidazole-2 carboxamide, 5-cyano-n-[2-(1-cyclohexen-1...|JNJ-28312141"	1149939558	name	FALSE
JNJ-38877605	d20c8cd172ed66d800ec95c565fd144b	JNJ-38877605	[NCGC00263189]	Hgfr (met; C-met) Inhibitor	"[Hgfr (met; C-met) Inhibitor, Hepatocyte Growth Factor Receptor Inhibitor, Hgfr Inhibitor]"	MET	[Phase I]	[Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1]	943540-75-8	943540758	759095	JNJ-38877605	Clinical trial	"PK:YK,MET"	"jnj 38877605|6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)-1,2,4-triazolo[...|JNJ-38877605"		name	FALSE
KX-01	97e9566a610f4b3406c30058672ca67f	KX-01	[NCGC00346644]	Src Kinase Inhibitor	"[Src Kinase Inhibitor, Src Kinase Inhibitors, Tubulin Polymerization Inhibitors, Tubulin Polymerization Inhibitor, Src Kinase Family Inhibitor, Tyrosine-protein Kinase Csk Inhibitior]"	SRC	"[Phase III, Phase II]"	[O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1]	1038395-65-1	1038395651	756643	KX-01	Clinical trial	"PK:YK,SRC"	"kx2-391|2-pyridineacetamide, 5-[4-[2-(4-morpholinyl)ethoxy]pheny...|KX-01|KXO-1|kx01"	897016829	name	FALSE
LGH-447	4de824102ae0f1a6c6be6efc6cde648f	LGH-447	[NCGC00510688]	Pim-1 Kinase Inhibitor	"[Pim-1 Kinase Inhibitor, Serine/threonine-protein Kinase Pim-1 Inhibitor, Serine/threonine-protein Kinase Pim-3 Inhibitor, Serine/threonine-protein Kinase Pim-2 Inhibitor]"	PIM1	"[Phase I/II, Unknown]"	"[C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)C1, C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1]"	1210608-43-7	1210608437	794109	LGH-447	Clinical trial	PK:PIM1	lgh-447 2hcl|pim447 dihydrochloride|cs-5941|lgh447 2hcl|pim-447 dihydrochloride|LGH-447|PIM-447	1820565692	name	FALSE
MGCD-265	c56fea335c95d427a26bcc5e29a815ea	MGCD-265	[NCGC00346510]	Hgfr (met; C-met) Inhibitor	"[Hgfr (met; C-met) Inhibitor, Hgfr Inhibitor, Macrophage-stimulating Protein Receptor Inhibitor, Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Vascular Endothelial Growth Factor Receptor 3 Inhibitor, Angiopoietin-1 Receptor Inhibitor, Vascular Endothelial Growth Factor Receptor 1 Inhibitor, Hepatocyte Growth Factor Receptor Inhibitor, Macrophage Stimulating 1 Receptor (mst1r, Ron) Inhibitors Tie2 Receptor Inhibitors Vegfr-1 (flt-1) Inhibitors Vegfr-2 (flk-1/kdr) Inhibitors Vegfr-3 (flt4) Inhibitors]"	MET	"[Phase II, Preclinical]"	[Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1]	875337-44-3	875337443	791059	MGCD-265	Clinical trial	PK:VEGFR	ct-mg265|glesatinib|mgcd265|MGCD-265		name	FALSE
MI-503	09c44a6b21ed898c08ce21315acdb8a9	Mi-503	[NCGC00507854]	Histone Methyl Transferase Inhibitor	"[Histone Methyl Transferase Inhibitor, Menin/mll Interaction Inhibitor]"	KTM2A	"[Preclinical, Unknown]"	[Cc1c(CN2CCC(Nc3ncnc4sc(CC(F)(F)F)cc34)CC2)ccc2c1cc(C#N)n2Cc1cn[nH]c1]	1857417-13-0	1857417130	"785346, 787039"	"MI-503, MI-503"	"NA, Clinical trial"	"NA, KMT2A"	"mi 503|a-1399|mi-503|mi503, mi 503|a-1399|mi-503|mi503"	", "	"name, name"	"TRUE, TRUE"
MIFEPRISTONE	3510f201e09b021cdc8b4d4a850f31c4	MIFEPRISTONE	"[NCGC00025179, NCGC00015700, NCGC00263908, NCGC00179632, NCGC00016952, NCGC00261486, MLS000069785, MLS001424271, NCGC00255152, MLS001074115]"	Progesterone Receptor Antagonist	"[Progesterone Receptor Antagonist, Glucocorticoid Receptor Antagonist, Internal Ribosomal Entry Site (ires) Inhibitor, Androgen Receptor Ligand]"	PGR	"[Unknown, Approved]"	"[CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C, CC#C[C@@]1(O)CC[C@@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@]21C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C, CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C, CC#C[C@]1(O)CCC2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C, CC#C[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](c3ccc(N(C)C)cc3)C[C@]21C, CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](c3ccc(N(C)C)cc3)C[C@@]21C]"	84371-65-3	84371653	652104	MIFEPRISTONE			17-.beta.-hydroxy-11-.beta.-(4-dimethylaminophenyl)-17-....|mifepristone		name	FALSE
MK-0752	88cbaaa81631785f23dd223df30d66ff	MK-0752	[NCGC00263184]	G-secretase Inhibitor	"[G-secretase Inhibitor, Gamma-secretase Inhibitor]"	PSN1	"[Phase II, Unknown, Phase I]"	"[O=C(O)CCC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1, O=C(O)CC[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1]"	471905-41-6	471905416	762831	MK-0752	Clinical trial	PSM|APH1|Gamma secretase	";3-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophen...|sri-013072|3-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluoropheny...|L-000891675|MK-0752|cs-0253"		name	FALSE
MK-8033	8bcc675493d5d076411d8d1e4cfdf015	MK-8033	[NCGC00378567]	Macrophage-stimulating Protein Receptor Inhibitor	"[Macrophage-stimulating Protein Receptor Inhibitor, Hgfr Inhibitor, Hepatocyte Growth Factor Receptor Inhibitor]"	MST1R	[Phase I]	[Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1]	1001917-37-8	1001917378	761692	MK-8033	Clinical trial	"PK:YK,MET"	"1-[3-(1-methyl-1h-pyrazo-4-yl)-5-oxo-5h-benzo[4,5]cycloh...|mk-8033"		name	FALSE
MK-886	56b75b73b58263af6c0ca1b1ce6caff2	MK-886	"[NCGC00016167, MLS002153424, NCGC00162249, NCGC00025106, NCGC00094113, MLS000758280, NCGC00381708, NCGC00261459]"	5-lipoxygenase-activating (flap) Inhibitor	"[5-lipoxygenase-activating (flap) Inhibitor, Arachidonate 5-lipoxygenase-activating Protein Inhibitor, Leukotriene Synthesis Inhibitor, Ppar Modulators]"	ALOX5AP	"[Phase II, Unknown]"	"[CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)[O-])n2Cc1ccc(Cl)cc1.[Na+], CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)O)n2Cc1ccc(Cl)cc1, CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)C(=O)[O-])n2Cc1ccc(Cl)cc1]"	118427-55-7	118427557	736463	MK-886			MK-886		name	FALSE
MONASTROL	f21a5868a0ac1818ddd6bfd139763357	Monastrol	[NCGC00025103]	Kinesin-like Protein Kif11 Inhibitor	"[Kinesin-like Protein Kif11 Inhibitor, Kinesin-like Spindle Protein Inhibitor]"	KIF11	"[Preclinical, Unknown]"	"[CCOC(=O)C1=C(C)NC(=S)N[C@H]1c1cccc(O)c1, CCOC(=O)C1=C(C)NC(=S)N[C@@H]1c1cccc(O)c1, CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1]"	254753-54-3	254753543	716782	MONASTROL			monastrol		name	FALSE
NAPABUCASIN	687cecf7ca04feab71af6bc52d43d594	NAPABUCASIN	[NCGC00390475]	Signal Transducer And Activator Of Transcription 3 Inhibitor	"[Signal Transducer And Activator Of Transcription 3 Inhibitor, Stat-3 Inhibitor]"	STAT3	[Phase III]	[CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O]	1134099-70-9	1134099709	788900	NAPABUCASIN	Clinical trial	CTNNB1|STAT3	;napabucasin;a-1960|napabucasin|a-1960|BBI-608	83280653	name	FALSE
NOSCAPINE	d897ec6def8082b79b406c186cdf3047	Noscapine	"[NCGC00023230, NCGC00015757, MLS001060855, NCGC00024322, NCGC00095305, MLS001076557, NCGC00016388, MLS000028523, MLS000104989, NCGC00017174, NCGC00180898, NCGC00261525, NCGC00087142, NCGC00094170, MLS000069475, NCGC00142420]"	Tubulin Polymerization Inhibitors	"[Tubulin Polymerization Inhibitors, Tubulin Polymerization Inhibitor]"	TUBB	"[Unknown, Approved]"	"[COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C.Cl, COc1ccc2c(c1OC)C(=O)O[C@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C, COc1ccc2c(c1OC)C(=O)O[C@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C.Cl, COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C.Cl, COc1ccc2c(c1OC)C(=O)OC2[C@@H]1c2c(cc3c(c2OC)OCO3)CCN1C, COc1ccc2c(c1OC)C(=O)O[C@H]2[C@@H]1c2c(cc3c(c2OC)OCO3)CCN1C, COc1ccc2c(c1OC)C(=O)OC2[C@@H]1c2c(cc3c(c2OC)OCO3)CCN1C.Cl, COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C, COc1ccc2c(c1OC)C(=O)O[C@H]2C1c2c(cc3c(c2OC)OCO3)CCN1C.Cl, COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C, COc1ccc2c(c1OC)C(=O)O[C@H]2C1c2c(cc3c(c2OC)OCO3)CCN1C, COc1ccc2c(c1OC)C(=O)OC2C1c2c(cc3c(c2OC)OCO3)CCN1C.Cl.O]"	912-60-7	912607	5366	NOSCAPINE	NA	NA	"narcotussin|narcotin|opian|1(3h)-isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahy...|narcompren|wln: t c566 do fo kn eh & & tj ho1 k1 j-dt56 bvo dhj ho1...|noscapine|narcotine (8ci)|noscapin|noscapal|noscapalin|.alpha.-narcotine|narcosine|nipaxon|coscopin (van)|phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy...|o-methylnarcotoline|opianin|terbenol|hederix (free base)|narkotin|methoxyhydrastine|l-.alpha.-narcotine|key-tusscapine|tusscapine|capval|longatin|narcotine|opianine|coscotabs|nsc 5366|lyobex|nectadon|vadebex|nicolane|1-.alpha.-narcotine"	128621	name	FALSE
NVP-BHG712	0342ef346f77acff06a7ad14009407d9	Nvp-bhg712	[NCGC00249391]	Raf Kinase B/c Inhibitor	"[Raf Kinase B/c Inhibitor, Serine/threonine-protein Kinase B-raf Inhibitor]"	BRAF	"[Preclinical, Unknown]"	[Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2c1cnn2C]	940310-85-0	940310850	820919	NVP-BHG712	NA	NA	bhg712|nvp-bhg712|bhg-712|ct-bhg712	940310850	cas	FALSE
OFLOXACIN	cb411f8e090d9d3f6b1a689bc118823b	Ofloxacin	"[NCGC00094219, MLS001165709, NCGC00261589, NCGC00178284, MLS001423977, NCGC00015772, NCGC00178529, MLS000028749, MLS001074203, NCGC00016948, MLS000759524]"	Antibiotic	"[Antibiotic, Dna Topoisomerase Ii Inhibitors; Antibiotic, Bacterial Dna Gyrase (mycobacterium Tuberculosis) Inhibitor, Dna Topoisomerase Iv Inhibitor, Bacterial Dna Topoisomerase Iv Inhibitor, Dna Topoisomerase Iv Inhibitors; Antibiotic, Bacterial Dna Gyrase Inhibitor]"	TOP2B	"[Unknown, Approved]"	"[C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.Cl, CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.Cl, C[C@@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23, CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23, C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23]"	100986-85-4	100986854	727071	OFLOXACIN	NA	NA	"ofloxacin|(+/-)-floxin|(+/-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piper..."	82419361	name	FALSE
OSIMERTINIB	2ca08a830dfaba03797a4b015efa6c1e	OSIMERTINIB	[NCGC00378622]	Epidermal Growth Factor Receptor (thr790met Mutant) Inhibitor	"[Epidermal Growth Factor Receptor (thr790met Mutant) Inhibitor, Egfr (thr790met Mutant) Inhibitor]"	EGFR	[Approved]	"[C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O, C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C]"	1421373-66-1	1421373661	"800812, 779217"	"OSIMERTINIB, OSIMERTINIB"	"NA, FDA approved"	"NA, PK:EGFR"	"NA, azd-9291|n-{2-[(2-dimethylaminoethyl)methylamino]-4-methoxy-5-[4-...|osimertinib|2-propenamide, n-[2-[[2-(dimethylamino)ethyl]methylamino...|azd9291"	", 1421373650"	"name, name"	"TRUE, TRUE"
OTSSP167	77d4144c6d13bcd413400cd46094a4f6	Otssp167	"[NCGC00389259, NCGC00386398]"	Maternal Embryonic Leucine Zipper Kinase Inhibitor	"[Maternal Embryonic Leucine Zipper Kinase Inhibitor, Melk Inhibitor]"	MELK	"[Phase I/II, Unknown]"	"[CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1, CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@@H](CN(C)C)CC1, CC(=O)c1cnc2c(c1NC1CCC(CN(C)C)CC1)NC(=C1C=C(Cl)C(=O)C(Cl)=C1)C=C2]"	1431698-10-0	1431698100	801013	OTSSP167	NA	NA	NA		name	FALSE
PACRITINIB	ce4b2823836aa6dc88e8aaf00e82b5fc	Pacritinib	"[NCGC00381564, NCGC00390623, NCGC00389254]"	Tyrosine-protein Kinase Jak2 Inhibitor	"[Tyrosine-protein Kinase Jak2 Inhibitor, Jak2 / Flt3 Inhibitor, Interleukin-1 Receptor-associated Kinase 1 Inhibitor, Macrophage Colony-stimulating Factor 1 Receptor Inhibitor, Cyclin-dependent Kinase 2 Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inhibitor, Tyrosine-protein Kinase Receptor Flt3 Inhibitor]"	JAK2	"[Phase III, Unknown]"	"[C1=C\COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1, C1=CCOCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC1.Cl, C1=CC2=N/C(=N\c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc2c3)N1, C1=CCOCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC1, C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1]"	937272-79-2	937272792	800814	PACRITINIB	NA	NA	NA		name	FALSE
PELITINIB	2ba2f57896449fe5932ca404c88c8c51	Pelitinib	[NCGC00263103]	Egfr (her1; Erbb1) Inhibitor	"[Egfr (her1; Erbb1) Inhibitor, Epidermal Growth Factor Receptor Inhibitor, Egfr Inhibitor]"	EGFR	"[Phase II, Unknown]"	"[CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C, CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C]"	257933-82-7	257933827	800841	PELITINIB	NA	NA	NA		name	FALSE
PEXMETINIB	ffb087e97b5f74c4281968bc3b64e2c6	Pexmetinib	[NCGC00481573]	Mitogen-activated Protein Kinase 14 Inhibitor	"[Mitogen-activated Protein Kinase 14 Inhibitor, P38 Mapk Inhibitor, Angiopoetin-1 Receptor Inhibitor]"	MAPK14	"[Unknown, Phase I]"	"[Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1, Cc1ccc(-n2nc(C(C)(C)C)cc2N/C(O)=N/Cc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1]"		NA	800844	PEXMETINIB	NA	NA	NA		name	FALSE
PF-03758309	af001659f6ea17c4de92a6682da63c16	PF-03758309	"[NCGC00387862, NCGC00345784]"	P21-activated Kinase 4 (pak4) Inhibitor	"[P21-activated Kinase 4 (pak4) Inhibitor, P21-activated Kinase 4 (pak4) Inhibitors, Serine/threonine-protein Kinase Pak 4 Inhibitor]"	PAK4	"[Discontinued, Phase I]"	"[Cc1nc(Nc2n[nH]c3c2CN(C(=O)NC(CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1, Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1, Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1]"	898044-15-0	898044150	781470	PF-03758309	Clinical trial	PK:PAK4	pf-03758309|a-1091|PF-3758309	1279034842	name	FALSE
PF-04217903	8cfcd1e2af97380ad92d46e2ff4e810e	PF-04217903	[NCGC00263161]	Hgfr (met; C-met) Inhibitor	"[Hgfr (met; C-met) Inhibitor, Hepatocyte Growth Factor Receptor Inhibitor, Hgfr Inhibitor]"	MET	"[Discontinued, Unknown, Phase I]"	"[OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1, CS(=O)(=O)O.OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1]"	1159490-85-3	1159490853	763931	PF-04217903	Clinical trial	PK:MET	202221|;pf-04217903;202221|pf-04217903|PF-4217903	956905274	name	FALSE
PF-04691502	2e51a91f06920a6f222d3df7d0fdbde6	PF-04691502	"[NCGC00346659, NCGC00381752]"	Phosphatidylinositol 3-kinase (pi3k) Inhibitor	"[Phosphatidylinositol 3-kinase (pi3k) Inhibitor, Pi3k Inhibitor, Serine/threonine-protein Kinase Mtor Inhibitor, Mtor, Frap1 Inhibitor]"	PIK3CA	"[Phase II, Phase I]"	"[COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1, COc1ccc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cn1]"	1013101-36-4	1013101364	"760536, 800846"	"PF-04691502, PF-04691502"	"Clinical trial, NA"	"PK:PIK3, NA"	"pf-04691502|2-amino-8-((1r,4r)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-m...|kin0000829|PF-4691502, NA"	", "	"name, name"	"TRUE, TRUE"
PF-477736	2df551f3eef426d5095b1f9b0885fe14	PF-477736	[NCGC00263132]	Chk1 Inhibitor	"[Chk1 Inhibitor, Serine/threonine-protein Kinase Chk1 Inhibitor]"	CHEK1	"[Discontinued, Unknown, Phase I]"	"[Cn1cc(-c2[nH]c3cc(NC(=O)C(N)C4CCCCC4)cc4c(=O)[nH]ncc2c34)cn1, Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c(=O)[nH]ncc2c34)cn1.[Cl].[Cl].[Cl], Cn1cc(-c2nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3-c2c[nH][nH]c4=O)cn1, Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c(=O)[nH]ncc2c34)cn1]"	952021-60-2	952021602	"800848, 763444"	"PF-477736, PF-477736"	"NA, Clinical trial"	"NA, PK:STK,CHEK,CHEK1"	"NA, pf-477736|(2r)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl...|PF-00477736"	", "	"name, name"	"TRUE, TRUE"
PHA-793887	fdffbdde93d40036016da4c8af3457f2	PHA-793887	[NCGC00263168]	Cdk Inhibitor	"[Cdk Inhibitor, Cyclin-dependent Kinase 4/cyclin D Inhibitor, Cdk4/cyclin D1 Inhibitor, Cdk5/p25 Inhibitor, Cdk1/cyclin B Inhibitor, Cdk2/cyclin A Inhibitor, Cdk2/cyclin E Inhibitor, Cdk1,2,3,4,5 Inhibitor]"	CDK4	[Phase I]	[CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C]	718630-59-2	718630592	800851	PHA-793887	NA	NA	NA		name	FALSE
PORFIROMYCIN	cb120c79abe15da2192ddd60f15811ff	Porfiromycin	"[MLS000766209, NCGC00246835]"	Dna Alkylating Drugs	"[Dna Alkylating Drugs, Dna-damaging Drugs, Dna Damaging Drugs, Dna Crosslinking Agent]"	H2AFX	"[Phase III, Unknown]"	"[CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@H]1[C@@H]2N1C, COC12[C@H](COC(N)=O)C3=C(C(O)=C(C)C(=N)C3=O)N1C[C@H]1[C@@H]2N1C, COC12C(COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1CC1C2N1C]"		NA	56410	PORFIROMYCIN		A7	"methyl mitomycin c|ent-50825|n-methylmitomycin c|wln:  t d3 b556 bn en jv mvttt&j e1 go1 h1ovz kz l1|porfiromycin|porphyromycin|methylmitomycin|porfiromycine|mitomycin c, n-methyl-|azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione,  6-ami...|porfiromycin(usan)"	801525	name	FALSE
PYROXAMIDE	1255009e8489f8114f84996f5be26b18	Pyroxamide	[NCGC00346891]	Hdac Inhibitor	"[Hdac Inhibitor, Histone Deacetylase (hdac) Inhibitor]"	HDAC1	"[Unknown, Phase I]"	[O=C(CCCCCCC(=O)Nc1cccnc1)NO]	382180-17-8	382180178	696085	PYROXAMIDE			"polar hybrid compound|n-hydroxy-n'-(3-pyridyl)-1,8-octanediamide|pyroxamide"		name	FALSE
R-406	7b53824003f392d24c2c13f07384fbfd	R-406	"[NCGC00182051, NCGC00601679]"	Tyrosine-protein Kinase Syk Inhibitor	"[Tyrosine-protein Kinase Syk Inhibitor, Syk Kinase Inhibitor, Interleukin-6 Production Inhibitor, Tnf-alpha Production Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inbitor, Interleukin-2 Production Inhibitor]"	SYK	"[Phase III, Phase II, Phase I]"	"[COc1cc(Nc2ncc(F)c(/N=c3\ccc4c([nH]3)N=C(O)C(C)(C)O4)n2)cc(OC)c1OC, COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC]"	841290-81-1	841290811	800858	R-406	NA	NA	NA		name	FALSE
R428	d33b725a0edc1e9d8ccc2b5202b99548	R428	"[NCGC00386665, NCGC00389622]"	Tyrosine-protein Kinase Receptor Ufo Inhibitor	"[Tyrosine-protein Kinase Receptor Ufo Inhibitor, Axl Kinase Inhibitor]"	AXL	"[Phase II, Unknown]"	"[Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2, Nc1nc(Nc2ccc3c(c2)CCC(N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2]"	1037624-75-1	1037624751	824183	R-428	NA	NA	r-428|bgb324|bemcentinib|r428	1037624751	cas	FALSE
RGB-286638	943d6a5dbffbfce44e0eb82cccb0bca1	RGB-286638	[NCGC00390582]	Cyclin-dependent Kinase/cyclin Complex Inhibitor	"[Cyclin-dependent Kinase/cyclin Complex Inhibitor, Cdk/cyclin Complex Inhibitor]"	CDK1	[Phase I]	[COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1]	784210-87-3	784210873	800866	RGB-286638	NA	NA	NA		name	FALSE
SAR-260301	4500f9b343b1c48e407c0969fd43fce7	Sar-260301	[NCGC00508867]	Pi3kbeta Inhibitor	"[Pi3kbeta Inhibitor, Phosphatidylinositol 3-kinase Beta Isoform Inhibitor]"	PIK3CB	"[Discontinued, Unknown]"	"[C[C@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1, C[C@@H]1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1, CC1Cc2ccccc2N1C(=O)Cc1nc(N2CCOCC2)cc(=O)[nH]1, CC1Cc2ccccc2N1C(=O)Cc1nc(=O)cc(N2CCOCC2)[nH]1]"	1260612-13-2	1260612132	"780290, 780291"	"SAR-260301 (ENANTIOMER 1), SAR-260301 (ENANTIOMER 1)"	"Clinical trial, Clinical trial"	"PI3KB, PI3KB"	"enantiomer p1 of sar-260301|a-1301|;a-1301;enantiomer p1 of sar-260301|SAR-260301 (enantiomer 1)|SAR-260301 (enantiomer 2)|Enantiomer P2 of SAR-260301, a-1301|enantiomer p2 of sar-260301|;enantiomer p2 of sar-260301;a-1301|SAR-260301 (enantiomer 1)|SAR-260301 (enantiomer 2)"	", "	"synonym, synonym"	"TRUE, TRUE"
SB-1317	ba49b015b7fd24edc95e353d899094d6	SB-1317	[NCGC00378999]	Cdk Inhibitor	"[Cdk Inhibitor, Cyclin-dependent Kinase 9/cyclin T1 Inhibitor, Cyclin Dependent Kinase Inhibitor, Tyrosine-protein Kinase Jak2 Inhibitor, Mitogen-activated Protein Kinase 7 Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inhibitor]"	CDK1	"[Phase I/II, Phase I]"	[CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1]	937270-47-8	937270478	"762673, 800879"	"SB-1317, SB-1317"	"Clinical trial, NA"	"PK:STK,CDK,ERK,FLT,JAK,FLT3, NA"	"cs-0884|sb-1317|tg-02|20-oxa-5,7,14,27-tetraazatetra-cyclo[19.3.1.12,6.18,12]h...|TG-2, NA"	"1204918728, "	"name, name"	"TRUE, TRUE"
SELINEXOR	1b8618c87d04af863339a9a9c9f98bc0	Selinexor	"[NCGC00386310, NCGC00480894]"	Exportin-1 Blocker	"[Exportin-1 Blocker, Exportin-1 Antagonist]"	XPO1	[Phase III]	"[O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1, O=C(/C=C/n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1]"	1421923-86-5	1421923865	780203	SELINEXOR	Clinical trial	XPO1	kpt-330|selinexor|cs-2185	1393477729	name	FALSE
SEMAXANIB	dddaf75e543c5967204d02707acd81e5	Semaxanib	"[NCGC00094381, NCGC00261795, NCGC00015972, MLS001332519, MLS001332520, MLS001074896]"	Flt3 Inhibitor	"[Flt3 Inhibitor, Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inbitor, Hepatocyte Growth Factor Receptor Inhibitor]"	KDR	"[Phase III, Phase II, Unknown]"	"[Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1, Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1, Cc1cc(C)c(/C=C2/C(=O)Nc3ccccc32)[nH]1]"	194413-58-6	194413586	696819	SEMAXANIB			"2H-Indol-2-one, 3-[(3,5-dimethyl-2-pyrrolyl)methylene]-|Semaxanib"		name	FALSE
SGI-1776	45bbab4327879b9500c7bafff7ef23a7	SGI-1776	[NCGC00263186]	Serine/threonine-protein Kinase Pim-1 Inhibitor	"[Serine/threonine-protein Kinase Pim-1 Inhibitor, Pim-1/flt3 Inhibitor, Serine/threonine-protein Kinase Pim Inhibitor Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inbitor]"	PIM1	"[Discontinued, Unknown, Phase I]"	"[CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1, CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1.O=S(=O)(O)O]"	1025065-69-3	1025065693	800883	SGI-1776	NA	NA	NA		name	FALSE
SONIDEGIB	56a30c3faede0378f0d68131d9200ed2	Sonidegib	"[NCGC00250382, NCGC00387854]"	Smoothened Receptor Antagonist	"[Smoothened Receptor Antagonist, Smo Receptor Antagonist]"	SMO	"[phase II, Unknown, Approved]"	"[Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1, Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1.O=P(O)(O)O.O=P(O)(O)O, Cc1c(C(=O)Nc2ccc(N3CC(C)OC(C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1]"	1218778-77-8	1218778778	761386	Sonidegib	FDA approved	SMO|Hg-Smo	"ct-lde225|sonidegib phospate|nvp-lde-225 (diphosphate salt)|a-1126|;nvd-lde225 (diphosphate salt);ct-lde225;cs-1175;lde225 ...|nvd-lde225 (diphosphate salt)|cs-1175|lde225 diphosphate|LDE-225|LDE-225, diphosphonate salt|d3582|N-[6-[(2R,6S)-2,6-Dimethyl-4-morphlinyl]-3-pyridinyl]-2-...|CT-LDE-225 (Diphosphate Salt)|sonidegib"	1218778778	cas	FALSE
SONOLISIB	3f32bf45c06da144a741b44ea3877a7f	Sonolisib	"[NCGC00387792, NCGC00390370, NCGC00388184]"	Phosphatidylinositol 3-kinase (pi3k) Inhibitor	"[Phosphatidylinositol 3-kinase (pi3k) Inhibitor, Na, Pi3k Inhibitor]"	PIK3CA	[Phase II]	"[C=CCN(/C=C1\C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C, C=CCN(/C=C1\C(=O)OC(COC)C2(C)C1=C(O)C(=O)C1=C2C(OC(C)=O)CC2(C)C(=O)CCC12)CC=C, C=CCN(/C=C1\C(=O)O[C@@H](COC)[C@]2(C)C1=C(O)C(=O)C1=C2[C@@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@H]12)CC=C, C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C]"	502632-66-8	502632668	"800933, 722134"	"SONOLISIB, SONOLISIB"	"NA, Clinical trial"	"NA, PK:PIK3"	"NA, px866|(bis-allyl)amino-wortmannin|px-866|sonolisib|Wortmannin Analog|DJM-166"	", 1351998838"	"name, name"	"TRUE, TRUE"
TAK-285	343be54a1a07ef4290f4935d2c06c06c	Tak-285	[NCGC00346699]	Egfr (her1; Erbb1) Inhibitor	"[Egfr (her1; Erbb1) Inhibitor, Epidermal Growth Factor Receptor Inhibitor, Egfr Inhibitor, Receptor Tyrosine-protein Kinase Erbb-2 Inhibitor]"	EGFR	"[Discontinued, Phase I]"	[CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21]	871026-44-7	871026447	800938	TAK-285	NA	NA	NA		name	FALSE
TAK-593	475c6b4829fb611f5658bd1f0960dc82	TAK-593	[NCGC00485933]	Vascular Endothelial Growth Factor Receptor 2 Inhibitor	"[Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Pdgfr Inhibitor, Platelet-derived Growth Factor Receptor Family Inhibitor, Vascular Endothelial Growth Factor Receptor 1 Inhibitor, Tyrosine Kinase Inhibitor]"	KDR	"[Discontinued, Phase I]"	[Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1]	1005780-62-0	1005780620	800939	TAK-593	NA	NA	NA		name	FALSE
TAK-659	713b94c1109ec1da051f09143361e9af	TAK-659	[NCGC00510693]	Tyrosine-protein Kinase Syk Inhibitor	"[Tyrosine-protein Kinase Syk Inhibitor, Syk Kinase Inhibitor, Receptor-type Tyrosine-protein Kinase Flt3 Inbitor]"	SYK	"[Phase II, Unknown]"	[Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1]	1952251-28-3	1952251283	"791967, 791968"	"TAK-659 (ISOMER 1), TAK-659 (ISOMER 1)"	"Clinical trial, Clinical trial"	"PK:SYK, PK:SYK"	"tak659 2hcl|tak-659 2hcl|TAK-659 (isomer 1)|TAK-659 (isomer 2), tak659|tak-659|TAK-659 (isomer 1)|TAK-659 (isomer 2)"	"1312691410, 1312691330"	"synonym, synonym"	"TRUE, TRUE"
TERAMEPROCOL	ba4e6ef5e07a247e7edfe3a2aca447d9	TERAMEPROCOL	"[NCGC00346832, NCGC00384872]"	Antimitotic Agent	"[Antimitotic Agent, Viral Tat (hiv) Inhibitor]"		"[Phase II, Unknown, Phase I]"	"[COc1ccc(CC(C)C(C)Cc2ccc(OC)c(OC)c2)cc1OC, COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC]"	24150-24-1	24150241	136955	TERAMEPROCOL			"dimethyldihydroguaiaretic acid|tetra-o-methyl nordihydroguaiaretic acid|butane, 1,4-bis(3,4-dimethoxyphenyl)-2,3-dimethyl-|benzene, 1,1'-(2,3-dimethyl-1,4-butanediyl)bis[3,4-dimet...|1,4-bis(3,4-dimethoxyphentl)-2,3-dimethylbutane|Terameprocol"	5701826	name	FALSE
THZ1	ced02ac2b52feaee5863576092a73eec	THZ1	[NCGC00389590]	Cdk 7 Inhibitor	"[Cdk 7 Inhibitor, Cyclin-dependent Kinase 7 Inhibitor]"	CDK7	"[Preclinical, Unknown]"	[CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1]	1604810-83-4	1604810834	825089	THZ-1	NA	NA	cs-3167|thz-1|thz1	1604810834	cas	FALSE
TOZASERTIB	d9fa2c2c82313413d7d5ffb3013cbb30	TOZASERTIB	"[NCGC00168110, MLS001065920]"	Aurora-a/b/c Kinase Inhibitor	"[Aurora-a/b/c Kinase Inhibitor, Aurora Kinase B Inhibitor, Bcr-abl (bcr-abl1) Kinase Inhibitor, Aurora Kinase A Inhibitor, Aurora Kinase C Inhibitor, Discoidin Domain-containing Receptor 2 Inhibitor, Receptor-type Tyrosine Protein Kinase Flt3 Inhibitor, Tyrosine-protein Kinase Jak2 Inhibitor, Abl1 Kinase Inhibitor]"	AURKB	"[Phase II, Discontinued, Unknown]"	"[C[C@H](O)C(=O)O.Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1, Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)[nH]n1, Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1]"	639089-54-6	639089546	800955	TOZASERTIB	NA	NA	NA		name	FALSE
TP-0903	42642821311c93faac3f9d9c5e36ce94	TP-0903	[NCGC00481577]	Aurora Kinase A Inhibitor	"[Aurora Kinase A Inhibitor, Axl Kinase Inhibitor, Aurora Kinase B Inhibitor, Tyrosine-protein Kinase Receptor Ufo Inhibitor]"	AXL	"[Unknown, Phase I]"	"[CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1, CN1CCN(Cc2ccc(Nc3ncc(Cl)/c(=N\c4ccccc4S(=O)(=O)N(C)C)[nH]3)cc2)CC1]"		NA	798200	TP-0903	Clinical trial	PK:AXL	tp0903|cs-4281|tp-0903	1341200450	name	FALSE
UMBRALISIB	9434e9c7aa57bb49a3355a227f985341	Umbralisib	"[NCGC00522500, NCGC00509910]"	Casein Kinase 1 Inhibitor	"[Casein Kinase 1 Inhibitor, Casein Kinase 1 Epsilon Inhibitor, Phosphatidylinositol 3-kinase Delta Isoform Inhibitor]"	CSNK1E	"[Phase III, Unknown]"	"[CC(C)Oc1ccc(-c2nn([C@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F, CC(C)Oc1ccc(-c2nn(C(C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F, CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F, CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1]"	1532533-69-9	1532533699	800405	UMBRALISIB	Clinical trial		cs-5243|tgr1202|tgr-1202|umbralisib	1532533677	name	FALSE
XANTHATIN	81366c8cdcb9e236c32df2e5d7478a5c	Xanthatin	"[NCGC00531743, NCGC00522633]"	Nf-kappab Activation Inhibitor	"[Nf-kappab Activation Inhibitor, Nf-kappab (nfkb) Activation Inhibitor, Prostaglandin G/h Synthase 2 Expression Inhibitor, Nitric Oxide Production Inhibitor]"	NFKB1	"[Preclinical, Unknown]"	"[C=C1C(=O)O[C@H]2C[C@H](C)C(/C=C/C(C)=O)=CC[C@H]12, C=C1C(=O)O[C@@H]2C[C@H](C)C(/C=C/C(C)=O)=CC[C@H]12, C=C1C(=O)OC2CC(C)C(/C=C/C(C)=O)=CCC12, C=C1C(=O)O[C@H]2C[C@H](C)C(/C=C/C(C)=O)=CC[C@@H]12]"	26791-73-1	26791731	136704	XANTHATIN			xanthatin		name	FALSE
Y-27632	5885dadd2fb5b5ac0dbf148d910a6e17	Y-27632	"[NCGC00261018, NCGC00387412, NCGC00381705, NCGC00016104, NCGC00389322, NCGC00093773, NCGC00092276]"	"Rock 1, Rock 2 Inhibitor"	"[Rock 1, Rock 2 Inhibitor, Rho-associated Protein Kinase 1 Inhibitor, Calcium Sensitizers, Leucine-rich Repeat Kinase 2 Inhibitor, Rho-associated Protein Kinase 2 Inhibitor]"	ROCK1	"[Preclinical, Unknown]"	"[C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1, C[C@H](N)C1CCC(C(=O)Nc2ccncc2)CC1, C[C@@H](N)C1CCC(C(=O)Nc2ccncc2)CC1.Cl.Cl, C[C@@H](N)C1CCC(C(=O)Nc2ccncc2)CC1, CC(N)C1CCC(C(=O)Nc2ccncc2)CC1, C[C@H](N)C1CCC(C(=O)Nc2ccncc2)CC1.Cl.Cl, C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1.Cl.Cl]"	146986-50-7	146986507	751297	Y-27632	Clinical trial	RHO	y27632 dihydrochloride|a-1931|y1021|y-27632 dihydrochloride|y-27632	129830382	name	FALSE
ZANUBRUTINIB	398346556f14ce9a7de4df5feb33d508	Zanubrutinib	"[NCGC00510501, NCGC00686202]"	Tyrosine-protein Kinase Btk Inhibitor	"[Tyrosine-protein Kinase Btk Inhibitor, Btk Inhibitor]"	BTK	"[Phase III, Unknown]"	"[C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1, C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1]"	1691249-45-2	1691249452	823807	Zanubrutinib	NA	NA	zanubrutinib|bgb3111|cs-0021869|bgb-3111	1691249452	cas	FALSE